Bionor is a biopharmaceutical company with first mover potential to advance a possible functional HIV cure

Latest news

Hide mandatory notifications of trade

Update from the Board of Directors

Financial .2016

(Oslo, Norway, 28 April 2016) Bionor Pharma ASA (OSE:BIONOR) announces that the Board of Directors is currently reviewing the company’s strategy and financing plans and will announce any possible changes in due course in a stock exchange announcement.

Three Bionor Pharma Board members collectively resign

Financial .2016

(Oslo, Norway, 28 April 2016) Bionor Pharma ASA (OSE:BIONOR) today announced that Benedicte Fossum, Kirsten Drejer and Jerome B. Zeldis collectively resign with immediate effect as board members in Bionor Pharma ASA owing to a shareholder led change in company strategy.

CEO leaves his position

Financial .2016

(Oslo, Norway, 26 April 2016) Bionor Pharma ASA (OSE:BIONOR) today announced that Dr. David Horn Solomon and Bionor’s Board of Directors have agreed that Dr. David Horn Solomon will leave his position as Chief Executive Officer of Bionor Pharma ASA, owing to a shareholder led change in company strategy.

Update from the Board of Directors

Financial .2016

(Oslo, Norway, 28 April 2016) Bionor Pharma ASA (OSE:BIONOR) announces that the Board of Directors is currently reviewing the company’s strategy and financing plans and will announce any possible changes in due course in a stock exchange announcement.

Three Bionor Pharma Board members collectively resign

Financial .2016

(Oslo, Norway, 28 April 2016) Bionor Pharma ASA (OSE:BIONOR) today announced that Benedicte Fossum, Kirsten Drejer and Jerome B. Zeldis collectively resign with immediate effect as board members in Bionor Pharma ASA owing to a shareholder led change in company strategy.

CEO leaves his position

Financial .2016

(Oslo, Norway, 26 April 2016) Bionor Pharma ASA (OSE:BIONOR) today announced that Dr. David Horn Solomon and Bionor’s Board of Directors have agreed that Dr. David Horn Solomon will leave his position as Chief Executive Officer of Bionor Pharma ASA, owing to a shareholder led change in company strategy.

Go to news section

Featured content